Precutaneous absorption accelerator and preparation containing same
August 3, 2008. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent References 3666671 Antiinflammatory analgesic gelled ointment Pharmaceutical preparations Pharmaceutical preparations Pharmaceutical preparations Use of eucalyptol for enhancing skin permeation of bio-affecting agents Polyol ether compound, preparation process thereof, and cosmetic composition containing same Transdermal medicament Patent #: 4746509 InventorsAssigneeApplicationNo. 07/227777 filed on 08/03/1988US Classes:514/420, Indomethacine per se or ester thereof424/449, Transdermal or percutaneous424/45, Organic pressurized fluid514/772, DESIGNATED ORGANIC NONACTIVE INGREDIENT CONTAINING OTHER THAN HYDROCARBON514/946, PENETRANT OR ABSORBENT (ENHANCES PENETRATION INTO SUBJECT TREATED)514/947, Topical application514/969, OINTMENT OR SALVE BASE568/628, Preparing by alkylation of benzene ring568/679, Polyether568/680, Polyhydroxy604/304Bandage, pad, or shield placed on body for sustained treatment thereofExaminersPrimary: Mars, Howard T.Attorney, Agent or FirmInternational ClassA61K 47/10 (20060101)Foreign Application Priority Data1984-04-23 JPAbstractA percutaneous absorption accelerator and a precutaneous absorbent preparation containing the same and, more particularly, a percutaneous absorption accelerator containing ether derivatives of specific glycerols or polyglycerols and alcohols as effective components and a percutaneous absorbent preparation containing the percutaneous absorption accelerators and pharmaceutically effective components.Other References
|
| ||||||||||||||
